[
  {
    "ts": null,
    "headline": "Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength?",
    "summary": "Amicus Therapeutics (FOLD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
    "url": "https://finnhub.io/api/news?id=1d2b2dc9f8799bd88f800e1f09b81dc44c5cd3152297bab849fa12dd214ccc66",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758292260,
      "headline": "Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength?",
      "id": 136820124,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Amicus Therapeutics (FOLD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
      "url": "https://finnhub.io/api/news?id=1d2b2dc9f8799bd88f800e1f09b81dc44c5cd3152297bab849fa12dd214ccc66"
    }
  }
]